Oliver Claire Watkins

Dr. Oliver Claire Watkins

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2016 in Phytochemical Analysis
Verified
Journal Article
Closed access
PDF file
DKDaniel Killeen
Daniel Killeen
OWOliver Claire Watkins
Oliver Claire Watkins
CSCatherine E. Sansom
Catherine E. Sansom
DADavid H. Andersen
David H. Andersen
Keith GordonKeith Gordon
Keith Gordon
NPNigel B. Perry
Nigel B. Perry

7 December 2020 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Open access
OWOliver Claire Watkins
Oliver Claire Watkins
HYHannah E.J. Yong
Hannah E.J. Yong
NSNeha Sharma
Neha Sharma
SCShiao-Yng Chan
Shiao-Yng Chan
Inositols, a group of 6-carbon polyols, are highly bioactive molecules derived from diet and endogenous synthesis. Inositols and their derivatives are involved in glucose and lipid metabolism and participate in insulin-signaling, with perturbations in inositol processing being associated with conditions involving insulin resistance, dysglycemia and dyslipidemia such as polycystic ovary syndrome and diabetes. Pregnancy is similarly characterized by substantial and complex changes in glycemic and lipidomic regulation as part of maternal adaptation and is also associated with physiological alterations in inositol processing. Disruptions in maternal adaptation are postulated to have a critical pathophysiological role in pregnancy complications such as gestational diabetes and pre-eclampsia. Inositol supplementation has shown promise as an intervention for the alleviation of symptoms in conditions of insulin resistance and for gestational diabetes prevention. However, the mechanisms behind these affects are not fully understood. In this review, we explore the role of inositols in conditions of insulin dysregulation and in pregnancy, and identify priority areas for research. We particularly examine the role and function of inositols within the maternal-placental-fetal axis in both uncomplicated and pathological pregnancies. We also discuss how inositols may mediate maternal-placental-fetal cross-talk, and regulate fetal growth and development, and suggest that inositols play a vital role in promoting healthy pregnancy.

19 February 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
OWOliver Claire Watkins
Oliver Claire Watkins
MSMiriam L. Sharpe
Miriam L. Sharpe
NPNigel B. Perry
Nigel B. Perry
KKKurt Krause
Kurt Krause
The New Zealand glowworm, Arachnocampa luminosa, is well-known for displays of blue-green bioluminescence, but details of its bioluminescent chemistry have been elusive. The glowworm is evolutionarily distant from other bioluminescent creatures studied in detail, including the firefly. We have isolated and characterised the molecular components of the glowworm luciferase-luciferin system using chromatography, mass spectrometry and 1H NMR spectroscopy. The purified luciferase enzyme is in the same protein family as firefly luciferase (31% sequence identity). However, the luciferin substrate of this enzyme is produced from xanthurenic acid and tyrosine, and is entirely different to that of the firefly and known luciferins of other glowing creatures. A candidate luciferin structure is proposed, which needs to be confirmed by chemical synthesis and bioluminescence assays. These findings show that luciferases can evolve independently from the same family of enzymes to produce light using structurally different luciferins.

28 March 2019 in Endocrinology
Verified
Journal Article
Closed access
PDF file
OWOliver Claire Watkins
Oliver Claire Watkins
MIMohammad Omedul Islam
Mohammad Omedul Islam
PSPreben Selvam
Preben Selvam
RPReshma Appukuttan Pillai
Reshma Appukuttan Pillai
AGAmaury Cazenave Gassiot
Amaury Cazenave Gassiot
SCShiao-Yng Chan
Shiao-Yng Chan
Placental lipid transport and metabolism is poorly understood despite its importance for fetal development and life-long health. We aimed to explore fatty acid (FA) processing in human villous placental explants from seven uncomplicated term singleton pregnancies delivered by elective cesarean section. Explants were treated with stable-isotope labeled palmitic acid (13C-PA), oleic acid (13C-OA) or docosahexaenoic acid (13C-DHA) for 3, 24 or 48 hours. Stable isotope labeled lipids synthesised by placental explants from labelled FA were quantified, alongside endogenous unlabeled placental lipids, by liquid-chromatography mass-spectrometry. Labeled phosphatidylcholines (PC), triacylglycerols (TAG), and phosphatidylethanolamines were detected in explants, whilst labeled lysophosphatidylcholines were found in both explants and conditioned-media. 13C-PA was primarily directed into PC synthesis (74% of 13C-PA-labeled lipids), while 13C-OA was directed almost equally into PC and TAG synthesis (45% and 53%, respectively, of 13C-OA-labeled lipids). 13C-DHA was only detectable in TAGs. TAGs demonstrated the highest isotopic enrichment for all 13C-FAs with 13C-OA-TAGs comprising >50% of total OA-TAGs (unlabelled and labeled); consistent with TAGs being a labile and accessible reservoir for FA storage. Variations in lipid incorporation were correlated to maternal glycemia and BMI suggesting that this experimental model could be used to investigate the effect of maternal factors on placental lipid metabolism. We conclude that lipid metabolic partitioning of freshly-imported FAs into labile and less labile lipid reservoirs in placenta is FA-dependent. This process may partly mediate the physiological preferential transplacental transfer of particular FAs to the fetus, but may also be implicated in the fetoplacental pathophysiology of maternal metabolic dysfunction.

5 March 2018 in Journal of Natural Products
Verified
Journal Article
Closed access
OWOliver Claire Watkins
Oliver Claire Watkins
NJNigel I. Joyce
Nigel I. Joyce
NGNick Gould
Nick Gould
NPNigel B. Perry
Nigel B. Perry

1 October 2019 in Journal of Endocrinology
Verified
Journal Article
Closed access
OWOliver Claire Watkins
Oliver Claire Watkins
MIMohammed Omedul Islam
Mohammed Omedul Islam
PSPreben Selvam
Preben Selvam
RPReshma Appukuttan Pillai
Reshma Appukuttan Pillai
AGAmaury Cazenave Gassiot
Amaury Cazenave Gassiot
SCShiao-Yng Chan
Shiao-Yng Chan
We postulate that myo-inositol, a proposed intervention for gestational diabetes, affects transplacental lipid supply to the fetus. We investigated the effect of myo-inositol on fatty acid processing in human placental explants from uncomplicated pregnancies. Explants were incubated with 13C-labeled palmitic acid, 13C-oleic acid and 13C-docosahexaenoic acid across a range of myo-inositol concentrations for 24 h and 48 h. The incorporation of labeled fatty acids into individual lipids was quantified by liquid chromatography mass spectrometry. At 24 h, myo-inositol increased the amount of 13C-palmitic acid and 13C-oleic-acid labeled lipids (median fold change relative to control = 1). Significant effects were seen with 30 µM myo-inositol (physiological) for 13C-palmitic acid-lysophosphatidylcholines (1.26) and 13C-palmitic acid-phosphatidylethanolamines (1.17). At 48 h, myo-inositol addition increased 13C-oleic-acid-lipids but decreased 13C-palmitic acid and 13C-docosahexaenoic-acid lipids. Significant effects were seen with 30 µM myo-inositol for 13C-oleic-acid-phosphatidylcholines (1.25), 13C-oleic-acid-phosphatidylethanolamines (1.37) and 13C-oleic-acid-triacylglycerols (1.32) and with 100 µM myo-inositol for 13C-docosahexaenoic-acid-triacylglycerols (0.78). Lipids labeled with the same 13C-fatty acid showed similar responses when tested at the same time point, suggesting myo-inositol alters upstream processes such as fatty acid uptake or activation. Myo-inositol supplementation may alter placental lipid physiology with unknown clinical consequences.